STAND.
COM. REP. NO. 137-22
Honolulu, Hawaii
, 2022
RE: H.B. No. 1794
H.D. 1
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirty-First State Legislature
Regular Session of 2022
State of Hawaii
Sir:
Your Committee on Government Reform, to which was referred H.B. No. 1794 entitled:
"A BILL FOR AN ACT RELATING TO OPIOIDS,"
begs leave to report as follows:
The purpose of this measure is to require the Department of Health to:
(1) By January 1, 2023, implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care and targeting improvements in outcomes for patients having opioid use disorders;
(2) Implement value-based purchasing based on these standardized quality metrics by July 1, 2023, to be applicable to all state purchases of health and human services entered into after July 1, 2023;
(3) Collect data from health service providers on levels of opioid prescriptions, use of opioids in health care settings, and patient interactions for opioid use disorders; and
(4) Annually report to the Legislature on the compiled data and any updates on the implementation of value-based purchasing.
Your Committee finds that the implementation of value-based purchasing, based on standardized quality metrics to improve the quality of care for patients having opioid use disorders, is a key component in addressing helping patients with opioid use disorder. However, your Committee recognizes that the underlying infrastructure for the value-based purchasing must be built first. Your Committee also believes that further research is needed to understand and address any major shifts in operations and clinical models that substance use disorder treatment providers may need before adjusting to efforts to incentivize new demands for higher quality of care.
Accordingly, your Committee has amended this measure by:
(1) Delaying the development and implementation of the standardized quality metrics until January 1, 2024;
(2) Delaying the implementation of value-based purchasing based on the standardized quality metrics until July 1, 2024;
(3) Establishing a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care;
(4) Requiring the working group to submit a report of its findings and recommendations, including proposed legislation, to the Legislature prior to the convening of the Regular Session of 2023;
(5) Changing its effective date to July 1, 2112, to encourage further discussion; and
(6) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Government Reform that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1794, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1794, H.D. 1, and be referred to your Committee on Health, Human Services, & Homelessness.
Respectfully submitted on behalf of the members of the Committee on Government Reform,
|
|
|
____________________________ ANGUS L.K. McKELVEY, Chair |
|
|
|
|